Search research articles
Contact Us
Filters
Showing results (201-210 of 248) with videos related to
Page
of 25
Sort By:
Hepatology (Baltimore, Md.)
|
July 8, 2011
Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells
Wen Sun, Jin Ding, Kun Wu, et al.
Hepatology (Baltimore, Md.)
|
August 31, 2010
Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
Le-Xing Yu, He-Xin Yan, Qiong Liu, et al.
Cancer Letters
|
February 16, 2013
Role of β-Catenin in regulating the balance between TNF-α- and Fas-induced acute liver injury
Shan-Shan Zou, Wen Yang, He-Xin Yan, et al.
Cancer Letters
|
November 30, 2016
Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment
Hui-Lu Zhang, Ming-Da Wang, Xu Zhou, et al.
Hepatology (Baltimore, Md.)
|
April 23, 2014
Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression
Bei-Fang Ning, Jin Ding, Jiao Liu, et al.
Journal of Hepatology
|
May 8, 2016
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α
Fu-Quan Wu, Tian Fang, Le-Xing Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 28, 2024
Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response
Jun Xue, Shuai Yang, Si-Si Zhang, et al.
Hepatology (Baltimore, Md.)
|
September 30, 2017
Distinct role of nuclear receptor corepressor 1 regulated de novo fatty acids synthesis in liver regeneration and hepatocarcinogenesis in mice
Qing Ou-Yang, Xi-Meng Lin, Yan-Jing Zhu, et al.
Hepatology (Baltimore, Md.)
|
January 29, 2011
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model
Yu-Xiong Feng, Tao Wang, Yue-Zhen Deng, et al.
Hepatology (Baltimore, Md.)
|
September 22, 2019
RPB5-Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding
Zheng-Hua Wan, Tian-Yi Jiang, Yuan-Yuan Shi, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 248) with videos related to
Sort By:
Page
of 25
Hepatology (Baltimore, Md.)
|
July 8, 2011
Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells
Wen Sun, Jin Ding, Kun Wu, et al.
Hepatology (Baltimore, Md.)
|
August 31, 2010
Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
Le-Xing Yu, He-Xin Yan, Qiong Liu, et al.
Cancer Letters
|
February 16, 2013
Role of β-Catenin in regulating the balance between TNF-α- and Fas-induced acute liver injury
Shan-Shan Zou, Wen Yang, He-Xin Yan, et al.
Cancer Letters
|
November 30, 2016
Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment
Hui-Lu Zhang, Ming-Da Wang, Xu Zhou, et al.
Hepatology (Baltimore, Md.)
|
April 23, 2014
Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression
Bei-Fang Ning, Jin Ding, Jiao Liu, et al.
Journal of Hepatology
|
May 8, 2016
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α
Fu-Quan Wu, Tian Fang, Le-Xing Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 28, 2024
Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response
Jun Xue, Shuai Yang, Si-Si Zhang, et al.
Hepatology (Baltimore, Md.)
|
September 30, 2017
Distinct role of nuclear receptor corepressor 1 regulated de novo fatty acids synthesis in liver regeneration and hepatocarcinogenesis in mice
Qing Ou-Yang, Xi-Meng Lin, Yan-Jing Zhu, et al.
Hepatology (Baltimore, Md.)
|
January 29, 2011
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model
Yu-Xiong Feng, Tao Wang, Yue-Zhen Deng, et al.
Hepatology (Baltimore, Md.)
|
September 22, 2019
RPB5-Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding
Zheng-Hua Wan, Tian-Yi Jiang, Yuan-Yuan Shi, et al.
Page
of 25